All studies
AuthorisedTherapeutic confirmatory (Phase III)Interventional

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Treatment, Prepubertal Children with Growth Hormone Deficiency (GHD)

Growth hormone deficiency means a child's body does not make enough natural growth hormone, causing slower growth and shorter adult height. Currently, standard care requires daily injections. This Phase 3 study tests whether an oral capsule called LUM-201 (ibutamoren mesylate), taken once a day by mouth, can help children grow safely. Researchers are comparing LUM-201 to a dummy capsule (placebo) over 12 months to measure yearly growth rates and check blood protein levels. Because the trial is double-blind, neither families nor doctors will know who receives the active medicine and who receives the placebo. The trial is open to young boys and girls who have confirmed growth hormone deficiency, have not yet reached puberty, and have never received growth hormone therapy before. Taking part could help doctors discover if a simple daily capsule can reduce the need for daily injections in the future.

At a glance

Status
Authorised
Phase
Therapeutic confirmatory (Phase III)
Sponsor
Lumos Pharma LLC
Enrolment target
68
Start
30 Oct 2026

What is this study about?

Growth hormone deficiency happens when the pituitary gland, a small gland at the base of the brain, does not produce enough growth hormone. Children with this condition grow much more slowly than other children their age. For decades, the main treatment has been daily injections of growth hormone under the skin. While effective, daily injections can be stressful, painful, and difficult for young children and their families to manage over many years.

This clinical trial is testing a new medicine called LUM-201. Unlike traditional injections, LUM-201 is taken by mouth as a capsule once a day. It works by encouraging the child's own body to release natural growth hormone. Researchers want to see if taking this capsule helps children grow at a healthy rate over a full year, while also testing its safety and monitoring key growth proteins in the blood.

This is a Phase 3 study, which means earlier research has shown promising results, and doctors are now testing the treatment in a larger group to confirm how well it works. If successful, an oral medicine could provide a kinder, injection-free alternative for children with growth hormone deficiency.

Key takeaways

  • Tests a daily oral capsule as an alternative to daily growth hormone injections.
  • Aimed at children with growth hormone deficiency who have not yet started puberty.
  • Participants must not have had any previous growth hormone treatments.
  • Runs for 12 months with regular hospital check-ups to track height and health.
  • Participation is voluntary and includes a chance of receiving a dummy capsule (placebo).

Who may be eligible?

This trial is for children who have been diagnosed with growth hormone deficiency but have never had any growth treatments before. Doctors refer to this as being 'treatment-naïve'.

To be suitable, children must be prepubertal, meaning their bodies have not yet started going through puberty. They must also be able to swallow a capsule each day and attend regular hospital check-ups with a parent or guardian.

Children who have already received growth hormone therapy in the past, or who have already started puberty, will not be able to join. The hospital research team will perform standard health checks and blood tests to confirm whether your child meets all the safety requirements.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. My child has been diagnosed with growth hormone deficiency.
  2. My child has never received growth hormone injections or treatments before.
  3. My child has not yet started puberty.
  4. My child is able and willing to swallow a capsule each day.
  5. We can attend regular hospital visits over a 12-month period.
Answer every question to see your result.

What does participation involve?

Taking part in this study lasts for 12 months. Your child will take one capsule by mouth every day at home. Because this is a randomised trial, your child will be randomly assigned to receive either LUM-201 or a matching dummy capsule (placebo). You and your child will have regular clinic visits over the year so doctors can measure their height and weight, check their general well-being, and take routine blood samples. You will also be asked to keep a simple diary noting when the medication is taken and reporting any possible side effects.

Potential risks and benefits

Your child will receive close, expert medical monitoring of their growth throughout the year, and taking part may help doctors develop an injection-free treatment for future children. However, there is no guarantee of personal benefit, and your child could be assigned to the placebo group. As with any medicine, LUM-201 may cause side effects such as changes in appetite or mild tummy upsets, though doctors will watch your child carefully. Joining is completely voluntary, and you can withdraw your child from the study at any time without any impact on their usual NHS care.

Locations (5)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Romania
  • —
    Unverified
    Poland
  • —
    Unverified
    Italy
  • —
    Unverified
    France
  • —
    Unverified
    Spain

Common questions

What is LUM-201 and how does it work?

LUM-201 is an experimental medicine taken by mouth. It signals the child's pituitary gland to release more of its own natural growth hormone.

Will my child definitely receive the active medicine?

No. This study uses a placebo (a dummy capsule), and a computer randomly decides who gets LUM-201 and who gets the placebo. Neither you nor the doctors will know which one your child receives.

How long does the study last?

The study treatment and monitoring period lasts for 12 months, with regular hospital check-ups throughout the year.

Are there any costs involved in taking part?

No. The study medication, clinic visits, and all health checks are provided free of charge, and travel costs are usually reimbursed.

What happens if we want to stop taking part?

You are free to leave the trial at any point. Your child will still receive standard NHS medical care and alternative growth treatments from their doctor.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.